Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Fuji
Mallinckrodt
Teva
Medtronic
Accenture
US Department of Justice
Chubb
McKinsey
Johnson and Johnson

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,882,452

« Back to Dashboard

Summary for Patent: 4,882,452
Title: Process for the preparation of ifosfamide having improved properties
Abstract:Ifosfamide having improved properties is obtained by crystallization from a solvent mixture selected from the group consisting of (a) a mixture of diethyl ether and a C.sub.1 -C.sub.3 alkanol or (b) a mixture of diisopropyl ether and a C.sub.1 -C.sub.3 alkanol under specific controlled conditions.
Inventor(s): Engel; Jurgen (Alzenau, DE), Muller; Siegfried (Bad Homburg, DE), Laubner; Werner (Halle, DE)
Assignee: Asta Pharma Akteingesellschaft (Frankfurt am Main, DE)
Application Number:07/163,586
Patent Claim Types:
see list of patent claims
Compound; Process; Formulation; Composition;

Drugs Protected by US Patent 4,882,452

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,882,452

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany3707154Mar 06, 1987

International Patents Family Members for US Patent 4,882,452

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 63121 ➤ Try a Free Trial
Canada 1305970 ➤ Try a Free Trial
Germany 3805329 ➤ Try a Free Trial
Germany 3862595 ➤ Try a Free Trial
Denmark 116988 ➤ Try a Free Trial
Denmark 168822 ➤ Try a Free Trial
European Patent Office 0281832 ➤ Try a Free Trial
Finland 86187 ➤ Try a Free Trial
Finland 881020 ➤ Try a Free Trial
Greece 3001898 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
UBS
US Department of Justice
Deloitte
Colorcon
QuintilesIMS
Harvard Business School
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot